In Brief: Smoking cessation product labeling
This article was originally published in The Tan Sheet
Executive Summary
Smoking cessation product labeling: FDA's Drug Abuse Advisory Committee will consider the issue at its June 9 meeting in the Versailles Ballroom at the Holiday Inn Bethesda, 8120 Wisconsin Ave., Bethesda, Md. ("The Tan Sheet" April 21, p. 8). The meeting will start at 8:30 a.m. with a one-hour open public hearing and is scheduled to conclude at 5:30 p.m. On June 10, the committee will discuss clinical trial design to study therapies for cocaine addiction beginning at 8:30 a.m...